T. Rowe Price Associates’s Liberty Live Group Series C LLYVK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.3M Sell
1,044,537
-297,017
-22% -$26.7M 0.01% 615
2025
Q4
$112M Sell
1,341,554
-146,829
-10% -$12.6M 0.01% 605
2025
Q3
$144M Buy
1,488,383
+940,484
+172% +$85M 0.02% 532
2025
Q2
$44.5M Buy
547,899
+277,124
+102% +$20.4M 0.01% 761
2025
Q1
$18.5M Buy
270,775
+238,707
+744% +$17M ﹤0.01% 977
2024
Q4
$2.18M Buy
32,068
+2,349
+8% +$149K ﹤0.01% 1607
2024
Q3
$1.53M Buy
29,719
+1,227
+4% +$49K ﹤0.01% 1768
2024
Q2
$1.09M Buy
28,492
+2,354
+9% +$91.2K ﹤0.01% 1861
2024
Q1
$1.15M Buy
26,138
+1,378
+6% +$52.7K ﹤0.01% 1852
2023
Q4
$926K Buy
24,760
+2,234
+10% +$76K ﹤0.01% 1901
2023
Q3
$724K Buy
+22,526
New +$746K ﹤0.01% 1944

Other funds holding LLYVK

T. Rowe Price Associates's LLYVK Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Liberty Live Group Series C (LLYVK) stake by 22% in Q1 2026, selling an estimated $26.7M and leaving 1,044,537 shares worth $98.3M. The position accounts for 0.01% of the portfolio, ranked #615.

T. Rowe Price Associates first reported a position in LLYVK in Q3 2023 and has held it in 11 quarters since. The position peaked at $144M in Q3 2025. 294 funds tracked by Wall St. Rank hold LLYVK as of Q1 2026.

  • T. Rowe Price Associates held 1,044,537 shares of Liberty Live Group Series C worth $98.3M as of Q1 2026.
  • T. Rowe Price Associates sold 297,017 Liberty Live Group Series C shares in Q1 2026, an estimated $26.7M.
  • Liberty Live Group Series C made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #615 holding.
  • T. Rowe Price Associates first reported a position in Liberty Live Group Series C in Q3 2023 and has held it in 11 quarters since.
  • T. Rowe Price Associates's Liberty Live Group Series C position peaked at $144M in Q3 2025.
  • 294 funds tracked by Wall St. Rank held Liberty Live Group Series C as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.